Product How it works Pricing Blog FAQ About Contact
Coherus Oncology

Coherus Oncology (NASDAQ: CHRS) net income

Coherus Oncology reported a net profit of $168.0m for fiscal 2025, 489.4% more than in fiscal 2024 ($28.5m). Its net margin was 398.4%. Earnings per share were $1.43.

Fiscal 2025 is the highest of the 10 fiscal years on record for Coherus Oncology. It reported a loss in 6 of those 10 years.

Net income, in millions of US dollars-127.32016-238.22017-209.3201889.82019132.22020-287.12021-291.82022-237.9202328.52024168.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$168.0m+489.4%398.4%$1.43
2024$28.5m—108.0%$0.25
2023−$237.9m—−92.5%−$2.53
2022−$291.8m—−138.2%−$3.76
2021−$287.1m−317.1%−87.9%−$3.81
2020$132.2m+47.2%27.8%$1.85
2019$89.8m—25.2%$1.29
2018−$209.3m——−$3.22
2017−$238.2m—−15,306.6%−$4.48
2016−$127.3m—−67.0%—

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Coherus Oncology net income compared with its sector

By net income for its latest fiscal year, Coherus Oncology ranks 97th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Coherus Oncology, 398.4%.

RankCompanyNet incomeNet margin
95thBio-Techne$181.9m15.0%
96thPenumbra$177.7m12.7%
97thCoherus Oncology$168.0m398.4%
98thConcentra Group Holdings Parent$166.4m7.7%
99thPediatrix Medical Group$165.4m8.6%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of Coherus Oncology

How much did Coherus Oncology earn in fiscal 2025?
Coherus Oncology reported a net profit of $168.0m for fiscal 2025. In fiscal 2024 it reported a net profit of $28.5m.
What are the earnings per share of Coherus Oncology?
They were $1.43 in fiscal 2025, compared with $0.25 in fiscal 2024.
What is the net margin of Coherus Oncology?
In fiscal 2025 its net profit was 398.4% of its revenue.
What was the most profitable year for Coherus Oncology?
Of its last 10 fiscal years, fiscal 2025, with $168.0m.
Where does Coherus Oncology rank in its sector by net income?
It ranks 97th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for Coherus Oncology come from?
From the annual report (Form 10-K) that Coherus Oncology files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Coherus Oncology files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Coherus Oncology: the Coherus Oncology page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.